Received Nov 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 4 | — | OT |
shortness of breath; This is a spontaneous report received from a Consumer or other non HCP and an Other HCP. Other Case identifier(s): MOD-2025-790763 (Moderna). A patient (age and gender not provided) received BNT162b2 (BNT162B2), on 14Nov2022 as dose 4(booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, SINGLE), for COVID-19 Immunization; Covid-19 vaccine (DOSE 2, SINGLE), for COVID-19 Immunization; Covid-19 vaccine (DOSE 3(BOOSTER), SINGLE), for COVID-19 Immunization. The following information was reported: DYSPNOEA (non-serious), outcome "unknown", described as "shortness of breath". Additional information: It was mentioned that patient received four doses of the Pfizer COVID-19 vaccine, with the most recent dose administered on November 14, 2022. Since then, has been experiencing shortness of breath for approximately a year and a half. The seeking information regarding potential long-term side effects associated with the Pfizer COVID-19 vaccine. It was unknown if the patient experienced any additional symptoms/events. Batch/lot number is not provided, and it cannot be obtained.